Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial.

Maiyue He,Jiaxuan Liu,Zijing Wang,Fei Ma,Jiayu Wang,Pin Zhang,Qing Li,Peng Yuan,Yang Luo,Ying Fan,Hongnan Mo,Bo Lan,Qiao Li,Binghe Xu

Breast (Edinburgh, Scotland)（2023）

引用 0|浏览18

暂无评分

摘要

The combination of metronomic capecitabine and pyrotinib is a promising regimen with competitive efficacy and improved tolerability in HER2 positive metastatic breast cancer patients.

查看译文

关键词

oral metronomic capecitabine,metastatic breast cancer,breast cancer,pyrotinib

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要